Lymph/angiogenesis contributes to sex differences in lung cancer through oestrogen receptor alpha signalling

Consensus guidelines for the use and interpretation of angiogenesis assays

(2018) Patrycja Nowak-Sliwinska et al.   ANGIOGENESIS

Lymphatic Vasculature Requires Estrogen Receptor-α Signaling to Protect From LymphedemaHighlights

(2018) Florent Morfoisse et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Emerging Concepts in Organ-Specific Lymphatic Vessels and Metabolic Regulation of Lymphatic Development

(2018) Brian W. Wong et al.   DEVELOPMENTAL CELL

Higher Lung Cancer Incidence in Young Women Than Young Men in the United States

(2018) Ahmedin Jemal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Influence of estrogen in non-small cell lung cancer and its clinical implications

(2018) Vianey Rodriguez-Lara et al.   Journal of Thoracic Disease

Organ-specific lymphatic vasculature: From development to pathophysiology

(2017) Tatiana V. Petrova et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Insufficient antibody validation challenges oestrogen receptor beta research

(2017) Sandra Andersson et al.   Nature Communications

Tumor lymphangiogenesis and new drug development

(2016) Lothar C. Dieterich et al.   ADVANCED DRUG DELIVERY REVIEWS

Accurate Control of 17β-Estradiol Long-Term Release Increases Reliability and Reproducibility of Preclinical Animal Studies

(2016) Céline Gérard et al.   JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA

G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1

(2015) Changyu Liu et al.   MEDICAL ONCOLOGY

US lung cancer trends by histologic type

(2014) Denise Riedel Lewis et al.   CANCER

Survival in Women with NSCLC: The Role of Reproductive History and Hormone Use

(2014) Hannah Katcoff et al.   Journal of Thoracic Oncology

Endothelial estrogen receptor isoforms and cardiovascular disease

(2014) Kyung Hee Kim et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Fulvestrant-Mediated Inhibition of Estrogen Receptor Signaling Slows Lung Cancer Progression

(2014) Hexiao Tang et al.   ONCOLOGY RESEARCH

What is personalized medicine: sharpening a vague term based on a systematic literature review

(2013) Sebastian Schleidgen et al.   BMC Medical Ethics

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

(2013)   LANCET

Estrogenic Steroid Hormones in Lung Cancer

(2013) Jill M. Siegfried et al.   SEMINARS IN ONCOLOGY

Enhanced expression of G-protein coupled estrogen receptor (GPER/GPR30) in lung cancer

(2012) Venkatakrishna Rao Jala et al.   BMC CANCER

Curcumin–cyclodextrin complexes potentiate gemcitabine effects in an orthotopic mouse model of lung cancer

(2012) N Rocks et al.   BRITISH JOURNAL OF CANCER

Stromal Estrogen Receptor-  Promotes Tumor Growth by Normalizing an Increased Angiogenesis

(2012) C. Pequeux et al.   CANCER RESEARCH

Sex Differences and Sex Steroids in Lung Health and Disease

(2012) Elizabeth A. Townsend et al.   ENDOCRINE REVIEWS

Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis

(2012) R. Cao et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Estrogen Signaling in Lung Cancer: An Opportunity for Novel Therapy

(2012) Christina S. Baik et al.   Cancers

Lung cancer mortality risk among breast cancer patients treated with anti-estrogens

(2011) Christine Bouchardy et al.   CANCER

Estrogen receptor β signaling regulates the progression of Chinese non-small cell lung cancer

(2011) Guangfeng Zhao et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Characteristics of lung cancer in women: Importance of hormonal and growth factors

(2011) Isabelle Rouquette et al.   LUNG CANCER

Lymphangiogenesis in post-natal tissue remodeling: Lymphatic endothelial cell connection with its environment

(2011) Jenny Paupert et al.   MOLECULAR ASPECTS OF MEDICINE

Interaction of tumor cells and lymphatic vessels in cancer progression

(2011) A Alitalo et al.   ONCOGENE

VEGFR-3 ligand-binding and kinase activity are required for lymphangiogenesis but not for angiogenesis

(2010) Luqing Zhang et al.   CELL RESEARCH

Genetic profiling and epidermal growth factor receptor-directed therapy in nonsmall cell lung cancer

(2010) J. Cadranel et al.   EUROPEAN RESPIRATORY JOURNAL

Prognostic Value of Vascular Endothelial Growth Factor Expression in Patients with Lung Cancer: A Systematic Review with Meta-Analysis

(2010) Ping Zhan et al.   Journal of Thoracic Oncology

Endothelial Estrogen Receptor-α Plays a Crucial Role in the Atheroprotective Action of 17β-Estradiol in Low-Density Lipoprotein Receptor–Deficient Mice

(2009) Audrey Billon-Galés et al.   CIRCULATION

Immunohistochemical Expression of Estrogen and Progesterone Receptors Identifies a Subset of NSCLCs and Correlates with EGFR Mutation

(2009) M. G. Raso et al.   CLINICAL CANCER RESEARCH

Estrogen receptor beta (ERβ) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells

(2009) Pamela A. Hershberger et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Menopausal hormone therapy and risk of lung cancer—Systematic review and meta-analysis

(2009) Claudia M. Greiser et al.   MATURITAS

Estrogen promotes tumor progression in a genetically defined mouse model of lung adenocarcinoma

(2008) Z. Hammoud et al.   ENDOCRINE-RELATED CANCER